搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Woman's World on MSN
2 分钟
Dealing with a Blocked Nostril? Here’s How to Clear It Fast!
Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...
The Healthy on MSN
9 天
Chronic Nasal Congestion: 7 Reasons You Always Feel Stuffed Up
It’s this inflammation of the lining of your nose that produces the telltale stuffiness sensation of chronic nasal congestion ...
health enews
2 天
Nasal congestion on one side? You may have this condition
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
来自MSN
31 分钟
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The therapy met the co-primary endpoint of the WAYPOINT ...
Onlymyhealth
4 天
From Allergies to Asthma, These Conditions Can Trigger Nasal Polyps
often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...
FiercePharma
6 小时
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
A phase 3 study has shown that when compared with placebo, Tezspire provided a statistically significant and clinically ...
ENDPOINTS NEWS
2 小时
Amgen and AstraZeneca share positive results in chronic rhinosinusitis
Amgen and AstraZeneca said on Friday that their asthma drug Tezspire reduced nasal congestion and the size of nasal ...
7 小时
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
14 小时
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
10 小时
on MSN
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
4 小时
AstraZeneca announces WAYPOINT trial met both co-primary endpoints
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
8 小时
Amgen, AstraZeneca announce top-line results from WAYPOINT trial
Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈